SML BIOPHARM
PrivateLast Round
Series B
Jul 21, 2025
Company Overview
SML BIOPHARM is a biotechnology company that develops advanced therapies using mRNA technology to treat a wide range of diseases, including personalized cancer vaccines and therapeutics for infectious and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SML BIOPHARM Comparables
Compare SML BIOPHARM with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Pantherna Therapeutics | 83% | |
| Genevant Sciences | 77% | |
| Kernalbio | 76% |
SML BIOPHARM Funding Rounds
Historical fundraising activity
SML BIOPHARM Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about SML BIOPHARM's valuation, stock price, and market status.
Is SML BIOPHARM a public or private company?
SML BIOPHARM is a private company.
What is the current stock price of SML BIOPHARM?
SML BIOPHARM is a private company, so its shares have no public market price. Caplight tracks SML BIOPHARM's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is SML BIOPHARM worth (valuation)?
Valuation information for SML BIOPHARM is not publicly available.
Can I buy SML BIOPHARM stock?
SML BIOPHARM shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was SML BIOPHARM's last funding round?
SML BIOPHARM's most recent funding round was Series B on July 21, 2025.
Who are the main investors in SML BIOPHARM?
Investor information for SML BIOPHARM is not publicly disclosed.
Will SML BIOPHARM IPO soon?
No public IPO plans have been announced for SML BIOPHARM.
How can I track SML BIOPHARM secondary market activity?
Caplight tracks bids, offers, and trades in SML BIOPHARM's shares on secondary markets.